Christopher Maltese, Chris serves as Chief Commercial Officer of GANIC Pharmaceuticals, Inc. Mr. Maltese has been Senior Vice President of Business Information and Analytics of Meda Pharmaceuticals, Inc. (formerly MedPointe Inc.) since 2005. Mr. Maltese has over twenty years of experience in leading teams within the finance, business development, information systems and market research areas. Over fifteen of those years are in the specialty pharmaceutical arena. He began his career in auditing for Litton Industries, Inc., a leading defense contractor. From 1986-1989, he worked as an internal auditor, moving in 1988 to the Airtron division working in product costing and pricing for the electronic warfare group. In 1989, he joined Carter-Wallace Inc. in the Wallace Pharmaceutical Division where he held many positions within the organization. During his tenure at Wallace Pharmaceutical, he held several senior positions within the finance, market research and business development groups. In 2001, he joined MedPointe as the Senior Director of Market Analysis when it acquired Carter-Wallace. He was promoted to Vice President for Business Analytics in 2002 and in early 2005 to his current position. He plays a key leadership role in its business information (IT), business development, analytics and market research activities. He received his BS in accounting from Rider University. He is a Certified Public Accountant licensed in NJ.
BUSINESS AND MANAGEMENT